Evaluated by: David B. Kaminsky, M.D., FIAC, March 21, 2018
Original release date: May 29, 2018
Access to this course expires on: March 21, 2021
Faculty: Christine Fuller, M.D.
- Understand the diagnostic criteria for diffuse midline glioma, H3 K27M mutant
- Recognize the cytologic appearance of medulloblastoma (CNS embryonal tumors), and be familiar with the appropriate molecular workup for genetic subgrouping
- Understand the diagnostic criteria for atypical teratoid / rhabdoid tumor (as per current 2016 WHO criteria)
$59.00 - $79.00